TSE:ACB - Aurora Cannabis Inc. (ACB.TO) Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$11.91
  • Forecasted Upside: -12.72 %
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$13.65
▼ -0.89 (-6.12%)
1 month | 3 months | 12 months
Get New Aurora Cannabis Inc. (ACB.TO) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$11.91
▼ -12.72% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Aurora Cannabis Inc. (ACB.TO) in the last 3 months. The average price target is C$11.91, with a high forecast of C$18.50 and a low forecast of C$7.80. The average price target represents a -12.72% upside from the last price of C$13.65.
Hold
The current consensus among 8 polled investment analysts is to hold stock in Aurora Cannabis Inc. (ACB.TO). This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 2 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 2 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 2 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 2 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 1 sell ratings
11/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
2/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/24/2021Jefferies Financial GroupBoost Price TargetC$4.59 ➝ C$9.44
i
2/16/2021CIBCBoost Price TargetUnderperformC$18.50
i
2/12/2021Canaccord GenuityBoost Price TargetC$11.00 ➝ C$14.00
i
2/12/2021MKM PartnersReiterated RatingSell
i
2/12/2021Stifel NicolausBoost Price TargetC$6.50 ➝ C$7.80
i
2/12/2021ATB CapitalBoost Price TargetSector PerformC$10.50 ➝ C$13.00
i
2/8/2021CIBCBoost Price TargetC$15.00 ➝ C$17.00
i
11/17/2020ATB CapitalUpgradeUnderperform ➝ Sector Perform
i
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector Perform
i
Rating by D. Kideckel at Atb Cap Markets
11/16/2020Jefferies Financial GroupLower Price TargetUnderperformC$6.90 ➝ C$4.93
i
11/10/2020CIBCBoost Price TargetC$12.00 ➝ C$15.00
i
11/10/2020CowenBoost Price TargetC$10.00 ➝ C$16.00
i
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ Underperform
i
Rating by D. Kideckel at Atb Cap Markets
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral
i
Rating by P. Zuanic at Cantor Fitzgerald
10/28/2020Stifel NicolausLower Price TargetC$10.50 ➝ C$3.60
i
9/29/2020Jefferies Financial GroupLower Price TargetC$8.70 ➝ C$6.90
i
9/24/2020CIBCLower Price TargetC$20.00 ➝ C$12.00
i
9/23/2020ATB CapitalLower Price TargetC$11.30 ➝ C$10.25
i
9/23/2020CowenLower Price TargetC$11.00 ➝ C$10.00
i
9/23/2020MKM PartnersLower Price TargetC$18.00 ➝ C$9.00
i
9/23/2020Pi FinancialLower Price TargetNeutralC$12.00 ➝ C$10.00
i
9/21/2020Canaccord GenuityLower Price TargetC$21.00 ➝ C$10.00
i
9/9/2020Stifel NicolausLower Price TargetC$16.00 ➝ C$10.50
i
9/9/2020ATB CapitalBoost Price TargetC$10.40 ➝ C$11.30
i
8/18/2020CIBCLower Price TargetC$24.00 ➝ C$20.00
i
6/24/2020Stifel NicolausUpgradeSell ➝ HoldC$6.20 ➝ C$17.50
i
6/24/2020Canaccord GenuityLower Price TargetC$24.00 ➝ C$21.00
i
5/28/2020AltaCorp CapitalBoost Price TargetC$2.50 ➝ C$10.40
i
Rating by D. Kideckel at AltaCorp Capital
5/25/2020CIBCBoost Price TargetC$14.00 ➝ C$24.00
i
5/22/2020Jefferies Financial GroupBoost Price TargetUnderperformC$12.00 ➝ C$14.00
i
5/19/2020Canaccord GenuityLower Price TargetC$27.00 ➝ C$24.00
i
5/19/2020CIBCLower Price TargetC$27.00 ➝ C$14.00
i
5/19/2020MKM PartnersBoost Price TargetC$12.00 ➝ C$18.00
i
5/18/2020CowenLower Price TargetC$12.00 ➝ C$11.00
i
5/12/2020CowenLower Price TargetC$12.00
i
5/12/2020Eight CapitalBoost Price TargetC$2.00 ➝ C$11.00
i
5/6/2020Pi FinancialSet Price TargetNeutralC$2.00
i
4/16/2020Jefferies Financial GroupLower Price TargetC$1.90 ➝ C$1.00
i
3/16/2020MKM PartnersLower Price TargetC$1.75 ➝ C$1.00
i
2/16/2020CIBCLower Price TargetC$2.50 ➝ C$2.25
i
2/16/2020Pi FinancialSet Price TargetNeutralC$2.00
i
2/14/2020Canaccord GenuityLower Price TargetC$3.00 ➝ C$2.25
i
2/10/2020Pi FinancialDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
i
2/10/2020CIBCLower Price TargetC$5.00 ➝ C$2.50
i
2/7/2020Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$6.00 ➝ C$3.00
i
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralC$6.00 ➝ C$2.00
i
2/7/2020Stifel NicolausLower Price TargetC$1.75 ➝ C$1.00
i
12/24/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$7.00 ➝ C$3.00
i
12/18/2019AltaCorp CapitalReiterated RatingSector Perform
i
Rating by D. Kideckel at AltaCorp Capital
12/17/2019LaurentianSet Price TargetBuyC$4.75
i
11/20/2019Pi FinancialLower Price TargetBuyC$7.00 ➝ C$6.00
i
11/15/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight
i
Rating by P. Zuanic at Cantor Fitzgerald
11/5/2019Cantor FitzgeraldReiterated RatingNeutral
i
Rating by P. Zuanic at Cantor Fitzgerald
10/11/2019Jefferies Financial GroupLower Price TargetC$14.00 ➝ C$7.00
i
9/24/2019CIBCReiterated RatingNeutralC$7.00
i
9/16/2019Stifel NicolausDowngradeHold ➝ SellC$7.00 ➝ C$5.00
i
9/13/2019DesjardinsLower Price TargetBuyC$16.50 ➝ C$14.00
i
Rating by J. Chu at Desjardins
5/3/2019Jefferies Financial GroupBoost Price TargetC$12.00 ➝ C$14.00
i
4/26/2019DesjardinsReiterated RatingBuyC$16.50
i
Rating by J. Chu at Desjardins
4/17/2019Bank of AmericaReiterated RatingBuyC$15.00
i
3/5/2019CowenReiterated RatingOutperformC$14.00
i
2/25/2019Jefferies Financial GroupReiterated RatingBuyC$12.00
i
2/21/2019Seaport Global SecuritiesReiterated RatingNeutral
i
Rating by B. Hundley at Seaport Global Securities
1/9/2019Eight CapitalLower Price TargetC$17.00 ➝ C$15.00
i
9/26/2018Canaccord GenuityBoost Price TargetC$11.00 ➝ C$13.00
i
8/2/2018Eight CapitalReiterated RatingBuyC$9.00
i
4/18/2018Canaccord GenuityUpgradeHold ➝ Speculative BuyC$10.50 ➝ C$11.00
i
3/16/2018Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$4.45 ➝ C$11.00
i
11/13/2017Canaccord GenuityBoost Price TargetC$3.65 ➝ C$4.45
i
11/3/2017Canaccord GenuityBoost Price TargetC$3.25 ➝ C$3.65
i
9/27/2017Canaccord GenuityBoost Price TargetSpeculative BuyC$2.85 ➝ C$3.25
i
12/14/2016Canaccord GenuityBoost Price TargetC$2.75 ➝ C$3.15
i
11/2/2016Canaccord GenuitySet Price TargetSpeculative BuyC$2.75
i
(Data available from 2/26/2016 forward)
Aurora Cannabis Inc. (ACB.TO) logo
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Today's Range

Now: C$13.65
C$13.56
C$14.60

50 Day Range

MA: C$15.23
C$12.67
C$23.96

52 Week Range

Now: C$13.65
C$4.93
C$26.79

Volume

3,039,633 shs

Average Volume

6,547,378 shs

Market Capitalization

C$2.69 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis Inc. (ACB.TO)?

The following Wall Street analysts have issued research reports on Aurora Cannabis Inc. (ACB.TO) in the last year: AltaCorp Capital, Atb Cap Markets, ATB Capital, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cowen Inc, Eight Capital, Jefferies Financial Group Inc., MKM Partners, Pi Financial, and Stifel Nicolaus.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis Inc. (ACB.TO)?

10 Wall Street analysts have set twelve-month price targets for Aurora Cannabis Inc. (ACB.TO) in the last year. Their average twelve-month price target is C$11.91, suggesting a possible downside of 18.1%. CIBC has the highest price target set, predicting ACB will reach C$18.50 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of C$7.80 for Aurora Cannabis Inc. (ACB.TO) in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis Inc. (ACB.TO)?

Aurora Cannabis Inc. (ACB.TO) currently has 3 sell ratings and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACB, but not buy more shares or sell existing shares.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis Inc. (ACB.TO)?

How do I contact Aurora Cannabis Inc. (ACB.TO)'s investor relations team?

Aurora Cannabis Inc. (ACB.TO)'s physical mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company's listed phone number is +1-604-3625207. The official website for Aurora Cannabis Inc. (ACB.TO) is auroramj.com.